Methods Of Treating Autism With mGluR5 Antagonists

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20130190402A1
SERIAL NO

13713600

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

mGluR5 antagonists are used for the treatment of autism. The human treated by the methods of the invention can also have fragile X syndrome, epilepsy and anxiety.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BROWN UNIVERSITY69 BROWN STREET BOX 1822 PROVIDENCE RI 02912

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bear, Mark F Dartmouth, US 21 114
Huber, Kimberly M Dallas, US 6 23
Warren, Stephen T Atlanta, US 12 45

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation